High-intensity focused ultrasound therapy

review OA: closed CC0 ⤵ 18 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-07

This paper describes the application of high-intensity focused ultrasound (HIFU) therapy as a non-invasive treatment modality.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

High-intensity focused ultrasound therapy has received increasing interest in the management of benign uterine tumors. Either magnetic resonance or ultrasound imaging has been used to target and monitor the ablation process. This article provides an overview of the background, clinical use, treatment outcomes, and safety of high-intensity focused ultrasound in the treatment of uterine fibroids and adenomyosis, including a summary of clinical trials comparing magnetic resonance- or ultrasound-guided high-intensity focused ultrasound with other minimally invasive or surgical interventions. The potential of this treatment modality as an alternative uterus-sparing option for women with fibroids and adenomyosis is discussed.

My notes (saved in your browser only)

MeSH descriptors

Adenomyosis High-Intensity Focused Ultrasound Ablation Leiomyoma Uterine Neoplasms Adenomyosis Adenomyosis Female High-Intensity Focused Ultrasound Ablation High-Intensity Focused Ultrasound Ablation Humans Leiomyoma Leiomyoma Magnetic Resonance Imaging Organ Sparing Treatments Patient Selection Pregnancy Prospective Studies Randomized Controlled Trials as Topic Treatment Outcome Uterine Neoplasms

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (52)

Cited by (17)

Source provenance

europepmc
last seen: 2026-08-17T06:11:01.428247+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:20:13.663096+00:00
unpaywall
last seen: 2026-08-17T06:25:09.426038+00:00
License: CC0 · commercial use OK